Archean Chemical Industries Gears Up for Q3 Reveal on 4th February; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 3 Feb 2026 • 11:15 am
Posted by:
Archean Chemical Industries Q3 results FY26 are scheduled to be announced on 4th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Archean Chemical Industries Q3 Results 2026 Preview
- Archean Chemical Industries' revenue is expected to be in the range of ₹242.29 crore, a 0.76% YoY increase.
- Profit After Tax, or PAT, is projected to rise 203.02% YoY.
- Net profit is ₹47.82 crore, up 203.02% YoY
- EBITDA to rise 296.73%
Archean Chemical Industries Share Performance
- Over the past six months, Archean Chemical Industries's share price has fallen by 10.66% to ₹569.45.
- Moreover, over the past year, the stock has decreased by 2.46%.
- Despite this weak short-term performance, Archean Chemical Industries's stock has delivered a financially sound 6.56% return over the past 5 years.
- As of 3rd February 2026, the stock traded at ₹569.05 per share.
Key Factors to Watch for Archean Chemical Industries Q3 Results FY26
- Revenue Growth & Volumes: Performance of industrial salt and bromine segments, including volume growth and price realizations.
- EBITDA & Margin Trends: Impact of raw material costs, operating efficiency, and product mix on profitability.
- Bromine Derivatives Contribution: Progress in higher-margin bromine derivatives and specialty chemical products.
- Cash Flow & Balance Sheet: Operating cash flow generation, working capital management, and debt/interest cost levels.
- Management Guidance: Commentary on demand outlook, pricing environment, and capacity expansion plans for FY26.
Final Thoughts
Archean Chemical Industries will announce its Q3 FY26 results on 3rd February 2026. Analysts expect 0.76% revenue growth, a 203.02% rise in PAT, and a 9.17% fall in EBITDA. Archean Chemical Industries focuses on bromine & industrial salt businesses, with increasing emphasis on higher-margin bromine derivatives and speciality chemicals, along with capacity expansion and cost efficiency to improve long-term profitability.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Recent Articles
CDSL NSDL Q2 Earnings Preview: Can IPO Buzz Boost the Depositories' Results, Demat Account Additions, the Q1 FY27 Base, Valuation and What Investors Should Know Before the Numbers
6 October 2026
Hang Seng Index Extends Gains for a Second Day as Tech Stocks Support Sentiment: Closing at 24,280, Biotech and AI Lead, Levels to Watch, the US Yield Backdrop and What It Means for Indian Investors
6 October 2026
TajGVK Hotels Shares Down 26% in a Year, but Monarch Research Sees 49% Upside: The 26.4% Revenue CAGR Forecast, Why the Stock Fell, Earnings Quality, Valuation and the Risks Before You Buy
6 October 2026
Gold-Silver Ratio Hits 68: What It Means, Whether Investors Should Switch From Gold to Silver, What the Ratio Says After a 26% Gold Correction and How Experts Suggest Staggered Investing
6 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
CDSL NSDL Q2 Earnings Preview: Can IPO Buzz Boost the Depositories' Results, Demat Account Additions, the Q1 FY27 Base, Valuation and What Investors Should Know Before the Numbers
Hang Seng Index Extends Gains for a Second Day as Tech Stocks Support Sentiment: Closing at 24,280, Biotech and AI Lead, Levels to Watch, the US Yield Backdrop and What It Means for Indian Investors
TajGVK Hotels Shares Down 26% in a Year, but Monarch Research Sees 49% Upside: The 26.4% Revenue CAGR Forecast, Why the Stock Fell, Earnings Quality, Valuation and the Risks Before You Buy
Gold-Silver Ratio Hits 68: What It Means, Whether Investors Should Switch From Gold to Silver, What the Ratio Says After a 26% Gold Correction and How Experts Suggest Staggered Investing
Why Kotak Mahindra Bank Shares Beat the Nifty 50 and Bank Nifty in the Last Two Months: New CEO Clarity, Loan Growth, Improving Asset Quality, Goldman's Rs 540 Target and What Could Go Wrong
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times